skip to content


(should not be prescribed as rapamycin)


As an adjunct to or substitute to a calcineurin phosphatase inhibitor for immunosuppression in patients in whom ciclosporin/tacrolimus have been implicated in allograft pathology.


Hypersensivity to sirolimus and its derivatives.

Pregnancy and breast feeding

Presentation - 1mg and 2mg tablet

Dosage and Administration

Sirolimus is not used de-novo and is generally switched for tacrolimus. The following doses can be started and tacrolimus continued at half the current dose until sirolimus levels are therapeutic.

Doses should be given on an empty stomach.

Day 1    6mg daily

Day 2 onwards 2mg daily adjusted according to levels

Check sirolimus level at 1 week


Target range 5-15ng/ml depending on whether it is an adjunct to or substitute for a CNI.

Note that target in SMYPHONY study when used in place of a CNI was 4/8 ng/ml and many dropped out due to adverse events despite this lower goal level.


Side Effects

Raised triglycerides and cholesterol         

Thrombocytopeania     Mouth Ulceration  Proteinuria
Anaemia Neutropenia Diarrhoea
Hypokalaemia Arthalgia Epistaxis
Delayed wound healing Lymphocele Rash
Oedema Infections PTLD


Drug Interactions

Compounds which modulate CYP3A4 activity may affect Sirolimus levels.

Drugs which may increase sirolimus levels:

Diltiazem Bromocriptine Prokinetic agents
Azole antifungals Cimetidine Protease inhibitors
Macrolide antibiotics Danazol Grapefruit juice


Drugs which may decrease sirolimus levels:  Rifampicin, anticonvulsants





Azathioprine << | Immunosuppressive Drugs | >> ATG (Anti-thymocyte Globulin)

Licensed under a Creative Commons LicenseCreative Commons Attribution 4.0 International License.


This page last modified 05.03.2018 10:46 by Emma Farrell. edren and edrep are produced by the Renal Unit at the Royal Infirmary of Edinburgh and the University of Edinburgh. CAUTIONS and Contact us.